All HEI'sAthlone Institute of TechnologyCork Institute of TechnologyDublin City UniversityDublin Institute of TechnologyMaynooth UniversityNational University of Ireland, GalwayRoyal College of SurgeonsTeagascTrinity College DublinUniversity College CorkUniversity College DublinUniversity of LimerickWaterford Institute of Technology All SectorsFuture Networks and Communications, IoT Data Analytics, Management, Security, Privacy, Robotics and Artificial Intelligence (incl. Machine Learning)Digital Platforms, Content and Applications, Augmented & Virtual RealityConnected Health Medical DevicesDiagnosticsTherapeutics Food for HealthSmart & Sustainable Food Production and Processing Decarbonising the Energy SystemSustainable LivingAdvanced & Smart ManufacturingManufacturing & Novel MaterialsInnovation in Services and Business ProcessingSectorsResearch Theme Sub SectorsNovel colostrum based composition with gut health applications - Licensing Opportunity for Teagasc for November 2017Bovine colostrum and its derived component, IgG have been shown to alter the gut cell surface by increasing the number of attachment sites for health promoting bacteria, leading to their increased colonisation in vitro. ... pdf 140.3KBEnsifer based transformation of plant cells - Licensing Opportunity for Teagasc on November 2017This involves a novel method of transforming plant and fungal cells, for a wide range of crops. The primary technique for the generation of genetically modified (‘biotech’) crops utilises Agrobacterium tumefaciens in a p... pdf 246.3KBObjective medication adherence calculator A tool to aid patient adherence and optimise drug dosage Licensing Opportunity for RCSI June 2017Assessing adherence to medication is an essential element in the ongoing treatment of patients with chronic disease as well as in the development and trialling of new drugs. The current standard methods of adherence asse... pdf 379.5KBPanaColl- A collagen-based scaffold for the delivery of antibiotics and enhancement of tissue regeneration Licensing Opportunity for RCSI June 2017Osteomyelitis (OM) is an infection of bone caused by bacteria such as Staphylococcus Aureus (S. Aureus). The current gold standard treatment for chronic OM is debridement of the infected bone followed by administration o... pdf 462.2KBChemoGel - A thermoresponsive hydrogel for interventional oncology applications Licensing Opportunity from RCSI June 2017Thermoresponsive hydrogels have attracted significant attention for drug delivery due to their ability to phase-transition from an injectable liquid at room temperatures to a solid gel at physiological temperatures. Howe... pdf 507.4KB First 1234567891011121314151617181920212223 Last Print Bookmark Top